Type 2 Diabetes Painful Peripheral Neuropathy study

Up to one third of patients with diabetes develop peripheral neuropathy (nerve damage in the feet causing pain, weakness, feelings of pins and needles and/or loss of sensation).

Peripheral neuropathy is particularly prevalent in older patients with long-standing diabetes. Pain is the most disturbing symptom of diabetic peripheral neuropathy, as it can be severe or even debilitating, and can lead to significant disability and impact on quality of life.

This research project is testing a new treatment for painful diabetic peripheral neuropathy. You will be asked to take a combination of over-the-counter supplements daily over 16 weeks.

Participants will be required to undertake three visits in total; two onsite visits at the Royal Melbourne Hospital, Parkville (about 2-3 hours) and one via telehealth (about 30 minutes). We aim to study if these supplements are successful in reducing nerve pain in people with type 2 diabetes and to assess whether their mobility and quality of life also improves.

To be eligible for this study you must:

• live with type 2 diabetes
• be aged greater than 18 years, and
• have painful peripheral neuropathy.

If you have any queries, please contact:  diabetesendoresearch@mh.org.au

This study has received ethics approval from Royal Melbourne Hospital:

HREC Reference Number: HREC/97204/MH-2023